Impact and Cost-Effectiveness of Alternative Human Papillomavirus Vaccines for Preadolescent Girls in Mozambique: A Modelling Study
BMC health serv. res. (Online); 11 (1058), 2023
Mozambique has one of the highest rates of cervical cancer in the world. Human papillomavirus (HPV) vaccination was introduced in 2021. This study evaluated the health and economic impact of the current HPV vaccine (GARDASIL® hereafter referred to as GARDASIL-4) and two other vaccines (CECOLIN® and CER...
Uterine Cervical Neoplasms, Human Papillomavirus Viruses, Vaccination, Cost-Effectiveness Analysis, Mozambique, Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18/administration & dosage, Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18/immunology, Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18/therapeutic use, Socioeconomic Factors, Cumulative Trauma Disorders/diagnosis, Cumulative Trauma Disorders/drug therapy, Cumulative Trauma Disorders/prevention & control